AI assistant
AbbVie Inc. — Director's Dealing 2014
Jun 4, 2014
29755_dirs_2014-06-04_78ffe0c8-b770-4846-92b0-2526babda51f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-06-02
Reporting Person: SEVERINO MICHAEL (EVP, R&D and CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-02 | Common stock, $0.01 par value | A | 141625 | — | Acquired | 141625 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-02 | Option (right to buy) | $54.44 | A | 74309 | Acquired | 2024-06-01 | Common stock (74309) | Direct |
Footnotes
F1: This stock represents performance vested restricted stock under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have a stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,770 on 06/02/2015, 24,769 on 06/02/2016, and 24,770 on 06/02/2017.